Last updated: 2026-10-11 11:20:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $3,23, with a market capitalization of $15,40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,63 to $5,25. This page covers its latest market performance, valuation, price trends and company information.
$15,40M | |
$3,25 | |
$600,00 | |
$1,63 | |
$3,04 | |
96,70K | |
157,50K | |
-- | |
$5,25 | |
$1,63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) last closed at $3,04 as of 2026-10-09 22:33:00, unchanged from the previous close of $3,04.
During the latest regular trading session, HSCS traded between $1,63 and $600,00, with a volume of 96,70K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $3,89 to $3,23, representing a decline of 16,97% ($0,66).
The stock traded between $3,02 and $4,63 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 484,58 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 44,2%
HSCS is currently trading at $3,23, placing it 44,2% of the way from its 52-week low of $1,63 to its 52-week high of $5,25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.